Find your next paid study

University of California, Los AngelesNCT07761728

Actual pay is set by the research site.

Incisional Hernia of Anterior Abdominal Wall

Phasix Mesh Underlay During Loop Ileostomy Closure: A Single Center Prospective Trial

This prospective study will evaluate whether placement of long-acting absorbable Phasix mesh during loop ileostomy closure reduces the development of an incisi…

Corewell Health WestNCT07871630

~$10 – $1,125

Actual pay is set by the research site.

Cerebellar tDCS Stimulation in Children and Adult Women With Anorexia Nervosa Disorder- A Pilot Study

Hypothesis: Will the use of tDCS brain modulation in the cerebellum assist in restricted behaviors, social cognition and cognitive flexibility in women with an…

Anorexia Nervosa

University of Texas Southwestern Medical CenterNCT06286930

Actual pay is set by the research site.

Problem BehaviorAggressionSelf Injury

Basic and Applied Research on Extinction Bursts

Although highly effective, treatments like FCT include extinction, which can have adverse side effects. The extinction burst, an increase in the frequency or i…

Rutgers, The State University of New JerseyNCT05925101

Actual pay is set by the research site.

Phase 2

A Phase 2a Study of High Dose Testosterone Followed by Targeted Radioligand Therapy in Metastatic Castration Resistant Prostate Cancer

The purpose of this study is to evaluate whether high-dose testosterone followed by targeted radioligand therapy (TRT) is effective in treating metastatic cast…

Metastatic Castration-resistant Prostate Cancer

H. Lee Moffitt Cancer Center and Research InstituteNCT07476001

~$75 – $2,000

Actual pay is set by the research site.

Phase 1

Phase 1-2, Open-Label, Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION337 in Patients With Dravet Syndrome

The primary purpose of this study is to evaluate the safety and tolerability of ION337 in participants with Dravet syndrome (DS).

Dravet Syndrome

Ionis Pharmaceuticals, Inc.NCT07531745

~$150 – $4,200

Actual pay is set by the research site.

American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)

Despite many advances in our understanding of the natural history and progression of chronic kidney disease (CKD) and cardio vascular disease (CVD) in the pare…

Diabetes MellitusChronic Kidney DiseasesHeart Diseases+1 more

University of New MexicoNCT04185844

Actual pay is set by the research site.

Novel Extensions of Alcohol Contingency Management in People Living With HIV

In this project, the investigators will implement innovations to extend use of Contingency Management (CM) to facilitate alcohol use reduction among people liv…

Alcohol Use

University of FloridaNCT05153811

Actual pay is set by the research site.

Phase 1

Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors

This is a Phase 1 study of the combination of two drugs: MM-398 and Cyclophosphamide. The goal is to find the highest dose of MM-398 that can be given safely w…

Recurrent or Refractory Solid TumorsEwing SarcomaRhabdomyosarcoma+2 more

South Plains Oncology ConsortiumNCT02013336

~$150 – $4,500

Actual pay is set by the research site.

Psychosocial Impact of COVID-19 Pandemic on MD Anderson Workforce

This study investigates the impact of the COVID-19 pandemic on the psychosocial health of employees of MD Anderson Cancer Center. Epidemics have been shown to …

COVID-19 Infection

M.D. Anderson Cancer CenterNCT04491292

Actual pay is set by the research site.

Phase 4

Fluorescent Probe for Assessment of Renal Elimination

Accurate measures of kidney function is important for precision dosing of many medications. The current methods of determining kidney function largely hinge on…

Augmented Renal ClearanceCritical Illness

PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)

~$25 – $1,500

Actual pay is set by the research site.

Aaron CookNCT07643467

Phase 1

A Phase 1 Dose Escalation Trial Evaluating an Intravenously Administered Recombinant Adeno-Associated Virus Serotype rh.74 (AAVrh.74) Vector Containing the Human Plakophilin-2a (PKP2a) Coding Sequence (RP-A601; AAVrh.74-PKP2a) in Subjects With Arrhythmogenic Cardiomyopathy Arising From Pathogenic PKP2 Variants (PKP2-ACM)

This Phase 1 dose escalation trial will assess the safety and preliminary efficacy of a single dose intravenous infusion of RP-A601 in high-risk adult patients…